Next Article in Journal
Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
Next Article in Special Issue
Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?
Previous Article in Journal
A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations—Does One Model Type Fit All?
Previous Article in Special Issue
Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast—15-Year Follow-Up
 
 
Article

Article Versions Notes

Cancers 2022, 14(5), 1275; https://doi.org/10.3390/cancers14051275
Action Date Notes Link
article xml file uploaded 1 March 2022 11:40 CET Original file -
article xml uploaded. 1 March 2022 11:40 CET Update -
article pdf uploaded. 1 March 2022 11:40 CET Version of Record https://www.mdpi.com/2072-6694/14/5/1275/pdf-vor
article html file updated 1 March 2022 11:41 CET Original file -
article xml file uploaded 2 March 2022 10:41 CET Update -
article xml uploaded. 2 March 2022 10:41 CET Update https://www.mdpi.com/2072-6694/14/5/1275/xml
article pdf uploaded. 2 March 2022 10:41 CET Updated version of record https://www.mdpi.com/2072-6694/14/5/1275/pdf
article html file updated 2 March 2022 10:42 CET Update -
article html file updated 1 August 2022 03:32 CEST Update https://www.mdpi.com/2072-6694/14/5/1275/html
Back to TopTop